Ken Nelson, Head of Digital Health, Diagnostics, & Monitoring, Biotronik

Speakers
Scott Pantel
Scott Pantel
Founder & CEO, LSI
Ken Nelson
Ken Nelson
Head of Digital Health, Diagnostics, & Monitoring, Biotronik

Ken Nelson will attend the 2021 Emerging Medtech Summit to network and connect with other investors, strategics and innovators.  Ken presented at LSI's 2020 event as the Chief Commercialization Officer of Bardy Diagnostics.

Nelson currently serves as Head of Digital Health, Diagnostics, & Monitoring at Biotronik.  He has deep industry experience and a 20 year track record in digital health, medical device, and remote patient monitoring.  Nelson is an executive and innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which is well on its way to doing the same (Bardy Diagnostics).

LSI Asia ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

June 10th - 13th, 2025The Ritz-Carlton, Millenia Singapore Register arrow